651 participants
A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-08-07
- Start Date:
- 2020-09-30
- Completion:
- 2024-07-18
Conditions
- Respiratory Syncytial Virus
Interventions
- BIOLOGICAL
- DRUG
No Results Yet